𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis

✍ Scribed by Mathias Munk; Ashfaque Ahmed Memon; Ebba Nexo; Boe Sandahl Sorensen

Book ID
109052882
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
196 KB
Volume
99
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antisense oligonucleotides targeting the
Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
✍ Fortunato Ciardiello; Rosa Caputo; Teresa Troiani; Gaetano Borriello; Ekambar R. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 210 KB πŸ‘ 2 views

We have constructed a series of 22 phosphorothioate 20-mer antisense oligonucleotides directed against different regions of the human (EGFR) mRNA. Treatment with EGFR antisense oligonucleotides showed a dose-dependent inhibition of human GEO colon cancer cell growth in soft agar. Western blot analys

Inhibition of proliferation and inductio
Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (β€˜Iressa’) is independent of EGFR expression level
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant